Pacific Biosciences Of California (PACB) Operating Margin Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.39 Bn | 196.79 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.37 Bn | 122.89 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.28 Bn | 110.06 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.16 Bn | 73.63 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.65 Bn | 47.40 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 146.00 |
| 10 | Pacific Biosciences Of California | 417.83 Mn | 180.96 Mn | 12.64 Mn | -157.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -157.00 |
| Mar 31, 2026 | 113,203.00 |
| Dec 31, 2025 | 29,786.00 |
| Sep 30, 2025 | 5,919.00 |
| Jun 30, 2025 | 37,549.00 |
| Mar 31, 2025 | -94,487.00 |
| Dec 31, 2024 | -24,012.00 |
| Sep 30, 2024 | -1,220.00 |
| Jun 30, 2024 | -33,447.00 |
| Mar 31, 2024 | 2,494.00 |
| Dec 31, 2023 | 16,835.00 |
| Sep 30, 2023 | 8,282.00 |
| Jun 30, 2023 | 3,782.00 |
| Mar 31, 2023 | -89.00 |
| Dec 31, 2022 | -13,881.00 |
| Jun 30, 2022 | -6,889.00 |
| Mar 31, 2022 | -11,744.00 |
| Dec 31, 2021 | -9,120.00 |
| Jun 30, 2021 | 1,501.00 |
| Mar 31, 2021 | 9,345.00 |